Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of Medicinal Chemistry
|
March 3, 2012
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index
Gang Liu, Sunny Abraham, Lan Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Cancer Cell
|
December 12, 2018
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling
Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, et al.
Nature Biotechnology
|
January 10, 2008
A quantitative analysis of kinase inhibitor selectivity
Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Scientific Reports
|
October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Daniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
The Journal of Infectious Diseases
|
September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Journal of Medicinal Chemistry
|
April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
Jason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Nature Cancer
|
March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
Lei Shi, William Shen, Mindy I Davis, et al.
The Journal of Infectious Diseases
|
June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of Medicinal Chemistry
|
March 3, 2012
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index
Gang Liu, Sunny Abraham, Lan Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Cancer Cell
|
December 12, 2018
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling
Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, et al.
Nature Biotechnology
|
January 10, 2008
A quantitative analysis of kinase inhibitor selectivity
Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Scientific Reports
|
October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Daniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
The Journal of Infectious Diseases
|
September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Journal of Medicinal Chemistry
|
April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
Jason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Nature Cancer
|
March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
Lei Shi, William Shen, Mindy I Davis, et al.
The Journal of Infectious Diseases
|
June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Page
of 4